GNCA Annual SG&A
$14.71 M
+$326.00 K+2.27%
31 December 2021
Summary:
As of February 4, 2025, GNCA annual selling, general & administrative expenses is $14.71 million, with the most recent change of +$326.00 thousand (+2.27%) on December 31, 2021. During the last 3 years, it has risen by +$405.00 thousand (+2.83%).GNCA Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GNCA Quarterly SG&A
$3.60 M
+$473.00 K+15.13%
31 March 2022
Summary:
As of February 4, 2025, GNCA quarterly selling, general & administrative expenses is $3.60 million, with the most recent change of +$473.00 thousand (+15.13%) on March 31, 2022. Over the past year, it has dropped by -$72.00 thousand (-1.96%).GNCA Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GNCA TTM SG&A
-$1.62 B
-$37.19 M-2.35%
31 March 2022
Summary:
As of February 4, 2025, GNCA TTM selling, general & administrative expenses is -$1.62 billion, with the most recent change of -$37.19 million (-2.35%) on March 31, 2022. Over the past year, it has dropped by -$1.63 billion (-11122.71%).GNCA TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GNCA Selling, General & Administrative Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +2.3% | -2.0% | -10000.0% |
3 y3 years | +2.8% | +19.3% | -10000.0% |
5 y5 years | +9.5% | -1.0% | -10000.0% |
GNCA Selling, General & Administrative Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time | -4.6% | -19.5% | <-9999.0% |
Genocea Biosciences Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | $3.60 M(+15.1%) | $14.64 M(-0.5%) |
Dec 2021 | $14.71 M(+2.3%) | $3.13 M(-19.5%) | $14.71 M(-4.9%) |
Sept 2021 | - | $3.88 M(-3.7%) | $15.46 M(+1.6%) |
June 2021 | - | $4.03 M(+9.9%) | $15.22 M(+3.8%) |
Mar 2021 | - | $3.67 M(-5.3%) | $14.67 M(+2.0%) |
Dec 2020 | $14.39 M(+19.5%) | $3.88 M(+6.4%) | $14.39 M(+6.1%) |
Sept 2020 | - | $3.64 M(+4.7%) | $13.56 M(+7.0%) |
June 2020 | - | $3.48 M(+2.7%) | $12.67 M(+2.1%) |
Mar 2020 | - | $3.39 M(+11.3%) | $12.41 M(+3.1%) |
Dec 2019 | $12.04 M(-15.9%) | $3.04 M(+10.4%) | $12.04 M(+3.6%) |
Sept 2019 | - | $2.76 M(-14.3%) | $11.62 M(-10.4%) |
June 2019 | - | $3.22 M(+6.6%) | $12.96 M(-8.8%) |
Mar 2019 | - | $3.02 M(+14.8%) | $14.22 M(-0.6%) |
Dec 2018 | $14.31 M(+6.5%) | $2.63 M(-35.9%) | $14.31 M(+1.1%) |
Sept 2018 | - | $4.10 M(-8.3%) | $14.16 M(+2.5%) |
June 2018 | - | $4.47 M(+43.8%) | $13.81 M(+7.0%) |
Mar 2018 | - | $3.11 M(+25.5%) | $12.91 M(-3.9%) |
Dec 2017 | $13.43 M | $2.48 M(-33.9%) | $13.43 M(-9.3%) |
Sept 2017 | - | $3.75 M(+5.0%) | $14.81 M(+0.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2017 | - | $3.57 M(-1.7%) | $14.68 M(-3.0%) |
Mar 2017 | - | $3.63 M(-5.8%) | $15.14 M(-1.9%) |
Dec 2016 | $15.43 M(+10.3%) | $3.86 M(+6.6%) | $15.43 M(+0.5%) |
Sept 2016 | - | $3.62 M(-10.1%) | $15.35 M(-0.2%) |
June 2016 | - | $4.03 M(+2.6%) | $15.38 M(+5.9%) |
Mar 2016 | - | $3.92 M(+3.8%) | $14.52 M(+3.8%) |
Dec 2015 | $13.99 M(+43.5%) | $3.78 M(+3.7%) | $13.99 M(+9.4%) |
Sept 2015 | - | $3.65 M(+14.9%) | $12.79 M(+6.7%) |
June 2015 | - | $3.17 M(-6.4%) | $11.98 M(+7.3%) |
Mar 2015 | - | $3.39 M(+31.4%) | $11.17 M(+14.6%) |
Dec 2014 | $9.75 M(+96.5%) | $2.58 M(-9.3%) | $9.75 M(+8.1%) |
Sept 2014 | - | $2.84 M(+20.6%) | $9.02 M(+18.7%) |
June 2014 | - | $2.36 M(+19.9%) | $7.60 M(+24.2%) |
Mar 2014 | - | $1.97 M(+6.4%) | $6.12 M(+23.3%) |
Dec 2013 | $4.96 M(+34.4%) | $1.85 M(+29.8%) | $4.96 M(+18.3%) |
Sept 2013 | - | $1.42 M(+62.0%) | $4.19 M(+51.4%) |
June 2013 | - | $879.00 K(+8.5%) | $2.77 M(+46.5%) |
Mar 2013 | - | $810.00 K(-25.0%) | $1.89 M(+75.0%) |
Dec 2012 | $3.69 M(+22.8%) | $1.08 M | $1.08 M |
Dec 2011 | $3.00 M | - | - |
FAQ
- What is Genocea Biosciences annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Genocea Biosciences?
- What is Genocea Biosciences annual SG&A year-on-year change?
- What is Genocea Biosciences quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Genocea Biosciences?
- What is Genocea Biosciences quarterly SG&A year-on-year change?
- What is Genocea Biosciences TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Genocea Biosciences?
- What is Genocea Biosciences TTM SG&A year-on-year change?
What is Genocea Biosciences annual selling, general & administrative expenses?
The current annual SG&A of GNCA is $14.71 M
What is the all time high annual SG&A for Genocea Biosciences?
Genocea Biosciences all-time high annual selling, general & administrative expenses is $15.43 M
What is Genocea Biosciences annual SG&A year-on-year change?
Over the past year, GNCA annual selling, general & administrative expenses has changed by +$326.00 K (+2.27%)
What is Genocea Biosciences quarterly selling, general & administrative expenses?
The current quarterly SG&A of GNCA is $3.60 M
What is the all time high quarterly SG&A for Genocea Biosciences?
Genocea Biosciences all-time high quarterly selling, general & administrative expenses is $4.47 M
What is Genocea Biosciences quarterly SG&A year-on-year change?
Over the past year, GNCA quarterly selling, general & administrative expenses has changed by -$72.00 K (-1.96%)
What is Genocea Biosciences TTM selling, general & administrative expenses?
The current TTM SG&A of GNCA is -$1.62 B
What is the all time high TTM SG&A for Genocea Biosciences?
Genocea Biosciences all-time high TTM selling, general & administrative expenses is $15.46 M
What is Genocea Biosciences TTM SG&A year-on-year change?
Over the past year, GNCA TTM selling, general & administrative expenses has changed by -$1.63 B (-11122.71%)